Life-threatening bradyarrhythmia after massive azithromycin overdose

Pharmacotherapy

Volumn 26, Issue 1, 2006, Pages 147-150

  Tilelli, John A ^a,b,c   Smith, Kathleen M ^a   Pettignano, Robert ^d  

^a ARNOLD PALMER HOSPITAL FOR CHILDREN   (United States)

^b EMORY UNIVERSITY   (United States)

^c NEMOURS CHILDREN S HOSPITAL   (United States)

^d NONE

Author keywords

Azithromycin; Bradyarrhythmia; Macrolide antibiotics; QT interval prolongation; QTc; Torsade de pointes

Indexed keywords

ADRENALIN; ANTIFUNGAL AGENT; ASTEMIZOLE; ATROPINE; AZITHROMYCIN; BENZODIAZEPINE DERIVATIVE; CEFTRIAXONE; CYCLOSPORIN; CYTOCHROME P450 3A4; DILTIAZEM; ERYTHROMYCIN; FLUCONAZOLE; KETOCONAZOLE; PROTEINASE INHIBITOR; RIFABUTIN; TACROLIMUS; THEOPHYLLINE; TROLEANDOMYCIN; VERAPAMIL; WARFARIN;

ANTIBIOTIC THERAPY; ARTICLE; BRAIN HYPOXIA; CASE REPORT; COMPLETE HEART BLOCK; DRUG OVERDOSE; DRUG SAFETY; FEMALE; FEVER; HEART RHYTHM; HUMAN; HYPOKALEMIA; INFANT; INFANT DISEASE; INFECTION; MEDICATION ERROR; QT INTERVAL; QT PROLONGATION; RESUSCITATION; TORSADE DES POINTES;

ANTI-BACTERIAL AGENTS; ARRHYTHMIA; AZITHROMYCIN; CARDIOPULMONARY RESUSCITATION; ELECTROENCEPHALOGRAPHY; EPINEPHRINE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFANT; MEDICAL ERRORS;

EID: 30544437074     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2006.26.1.147     Document Type: Article

References (22)

1. Rezkalla MA, Pochop C. Erythromycin induced torsades de pointes: case report and review of the literature. South Dakota J Med 1994;47:161-4.
2. Wong CB, Windle J. Erythromycin induced torsades de pointes. Nebraska Med J 1995;80:285-6.
3. Walsh EP. Electrocardiography and introduction to electrophysiologic techniques. In: Fyler DC, ed. Nadas' pediatric cardiology. St. Louis, MO: Mosby, 1992:128.
4. Periti P, Mazzei T, Mini E, Novelli A. Adverse effects of macrolide antibacterials. Drug Saf 1993;9:346-64.
5. Gitler B, Berger LS, Buffa SD. Torsades de pointes induced by erythromycin. Chest 1994;105:368-72.
6. Brandriss MW, Richardson WS, Barold SS. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review. Clin Infect Dis 1994;18:995-8.
7. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.
8. Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004;351:1089-96.
9. Pai MP, Graci DM, Amsden GW. Macrolide drug interactions: an update. Ann Pharmacother 2000;34:495-512.
10. Shaffer D, Singer S, Korvick J, Honig P. Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the U.S. Food and Drug Administration adverse event reporting system. Clin Infect Dis 2002;35:197-200.
11. Strle F, Maraspin V. Is azithromycin treatment associated with prolongation of the QTc interval? Wien Klin Wochenschr 2002;14:396-9.
12. Ohtani H, Taninaka C, Hanada E, et al. Comparative pharmacodynamic analysis of QT interval prolongation induced by the macrolides clarithromycin, roxithromycin and azithromycin in rats. Antimicrob Agents Chemother 2000;44:2630-7.
13. Reed M, Wall GC, Shah NP, Heun JM, Hicklin GA. Verapamil toxicity resulting from a probably interaction with telithromycin. Ann Pharmacother 2005;35:357-60.
14. Kaeser YA, Brunner F, Drewe J, Haefeli WE. Severe hypotension and bradycardia associated with verapamil and clarithromycin. Am J Health-Syst Pharm 1998;15:2417-8.
15. Maxwell DL, Gimour-White SK, Hall MR. Digoxin toxicity due to interaction of digoxin with erythromycin [letter]. BMJ 1989;298:572.
16. Milan DJ, Peterson TA, Ruskin JN, Peterson RT, MacRae CA. Drugs that induce repolarization abnormalities cause bradycardia in zebra fish. Circulation 2003;107:1355-8.
17. Haefeli WE, Schoenberger RA, Weiss P, Ritz R. Possible risk for cardiac arrhythmias related to intravenous erythromycin. Intensive Care Med 1992;18:469-73.
18. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45.
19. American Heart Association. Handbook of emergency cardiovascular care. Dallas, TX: American Heart Association, 2002:88-9.
20. Niemann JT, Garner D, Khaleeli E, Lewis RJ. Milrinone facilitates resuscitation from cardiac arrest and attenuates postresuscitation myocardial dysfunction. Circulation 2003;108:3031-5.
21. American Society of Hospital Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993;50:305-14.
22. American Society of Health-System Pharmacists. ASHP guidelines: minimum standards for pharmacies in hospitals. Am J Health-Syst Pharm 1995;52:2711-17.